Breadcrumbs Home Media Press Releases Press Releases Press Releases Regulatory Press Releases More Press Releases Data Year2025202420232022202120202019201820172016201520142013201220112010 2024-12-10 20:30Moberg Pharma reports topline data in the North American phase 3 study and will regain rights to MOB-015 in EURead more 2024-11-12 08:00Moberg Pharma's Interim report January - September 2024Read more 2024-11-08 08:30Moberg Pharma's Nomination Committee appointedRead more 2024-09-13 08:00Moberg Pharma lowers expectations on primary endpoint in ongoing phase 3 trial following data in a subset of patientsRead more 2024-08-13 08:00Moberg Pharma's interim report January - June 2024Read more 2024-07-31 08:00New number of shares and votes in Moberg Pharma AB (publ)Read more Pagination First page Previous page Page 1 Page 2 Page 3 Current page 4 Page 5 Page 6 Page 7 Page 8 Page 9 … Next page Last page Press Releases Data Year2025202420232022202120202019201820172016201520142013201220112010 2024-11-08 08:30Moberg Pharma's Nomination Committee appointedRead more 2024-09-13 08:00Moberg Pharma lowers expectations on primary endpoint in ongoing phase 3 trial following data in a subset of patientsRead more 2024-08-13 08:00Moberg Pharma's interim report January - June 2024Read more 2024-07-31 08:00New number of shares and votes in Moberg Pharma AB (publ)Read more 2024-06-28 08:00New number of shares and votes in Moberg Pharma AB (publ)Read more 2024-06-24 17:35Moberg Pharma receives SEK 336 million through TO 2 and directed issue to top guarantors - subscription rate in TO 2 of 98%Read more Pagination First page Previous page Page 1 Page 2 Page 3 Current page 4 Page 5 Page 6 Page 7 Page 8 Page 9 … Next page Last page
